On behalf of the millions of Americans with cancer, whose very lives depend on our nation’s investment in oncology research, we ask that you join us now in urging congressional lawmakers to do the right thing: pass robust funding for the National Institutes of Health and the National Cancer Institute.
Clinical trials that test new therapeutic agents are fueled by discovery science from many sources, including laboratories funded by NIH, direct sponsorship by pharmaceutical companies, and those arising from partner research groups throughout the world.
Although the pharmaceutical industry plays an important role in developing new drugs, clinical oncology research funded by the U.S. government remains a particularly critical path for accelerating new therapies, providing transformative benefit to patients facing cancer.
